Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sandrine, Baghdoyan"'
Publikováno v:
Cells, Vol 12, Iss 4, p 571 (2023)
Myotonic dystrophy type 1 (DM1) is a progressive multisystemic disease caused by the expansion of a CTG repeat tract within the 3′ untranslated region (3′ UTR) of the dystrophia myotonica protein kinase gene (DMPK). Although DM1 is considered to
Externí odkaz:
https://doaj.org/article/d83bb0d9a77045a28ae4d89170594ab0
Autor:
Yves Maury, Pauline Poydenot, Benjamin Brinon, Lea Lesueur, Jacqueline Gide, Sylvain Roquevière, Julien Côme, Hélène Polvèche, Didier Auboeuf, Jérome Alexandre Denis, Geneviève Pietu, Denis Furling, Marc Lechuga, Sandrine Baghdoyan, Marc Peschanski, Cécile Martinat
Publikováno v:
iScience, Vol 11, Iss , Pp 258-271 (2019)
Summary: There is currently no treatment for myotonic dystrophy type 1 (DM1), the most frequent myopathy of genetic origin. This progressive neuromuscular disease is caused by nuclear-retained RNAs containing expanded CUG repeats. These toxic RNAs al
Externí odkaz:
https://doaj.org/article/11e934f15b8347d3af89003142c3acd6
Autor:
Delphine Laustriat, Jacqueline Gide, Laetitia Barrault, Emilie Chautard, Clara Benoit, Didier Auboeuf, Anne Boland, Christophe Battail, François Artiguenave, Jean-François Deleuze, Paule Bénit, Pierre Rustin, Sylvia Franc, Guillaume Charpentier, Denis Furling, Guillaume Bassez, Xavier Nissan, Cécile Martinat, Marc Peschanski, Sandrine Baghdoyan
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 4, Iss C (2015)
Major physiological changes are governed by alternative splicing of RNA, and its misregulation may lead to specific diseases. With the use of a genome-wide approach, we show here that this splicing step can be modified by medication and demonstrate t
Externí odkaz:
https://doaj.org/article/984842a497714948b5781bf1e6127059
Autor:
Laetitia, Barrault, Jacqueline, Gide, Tingting, Qing, Lea, Lesueur, Jorg, Tost, Jerome Alexandre, Denis, Michel, Cailleret, Laetitia, Aubry, Marc, Peschanski, Cécile, Martinat, Sandrine, Baghdoyan
Publikováno v:
Cells
Substantial variations in differentiation properties have been reported among human pluripotent cell lines (hPSC), which could affect their utility and clinical safety. We characterized the variable osteogenic capacity observed between different huma
Publikováno v:
médecine/sciences
médecine/sciences, EDP Sciences, 2019, 35 (1), pp.26-29. ⟨10.1051/medsci/2018316⟩
médecine/sciences, 2019, 35 (1), pp.26-29. ⟨10.1051/medsci/2018316⟩
médecine/sciences, EDP Sciences, 2019, 35 (1), pp.26-29. ⟨10.1051/medsci/2018316⟩
médecine/sciences, 2019, 35 (1), pp.26-29. ⟨10.1051/medsci/2018316⟩
International audience; No abstract available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c518d310f7f4a838afe4c75904d8254
https://hal.archives-ouvertes.fr/hal-02970141/file/msc180255.pdf
https://hal.archives-ouvertes.fr/hal-02970141/file/msc180255.pdf
Autor:
Pauline Poydenot, Cécile Martinat, Jacqueline Gide, Sandrine Baghdoyan, Julien Côme, Benjamin Brinon, Léa Lesueur, Marc Peschanski, Sylvain Roquevière, Yves Maury, Didier Auboeuf, Geneviève Piétu, Marc Lechuga, Denis Furling, Hélène Polvèche, Jérôme Alexandre Denis
Publikováno v:
iScience
iScience, Elsevier, 2019, 11, pp.258-271. ⟨10.1016/j.isci.2018.12.019⟩
iScience, 2019, 11, pp.258-271. ⟨10.1016/j.isci.2018.12.019⟩
iScience, Vol 11, Iss, Pp 258-271 (2019)
iScience, Elsevier, 2019, 11, pp.258-271. ⟨10.1016/j.isci.2018.12.019⟩
iScience, 2019, 11, pp.258-271. ⟨10.1016/j.isci.2018.12.019⟩
iScience, Vol 11, Iss, Pp 258-271 (2019)
Summary There is currently no treatment for myotonic dystrophy type 1 (DM1), the most frequent myopathy of genetic origin. This progressive neuromuscular disease is caused by nuclear-retained RNAs containing expanded CUG repeats. These toxic RNAs alt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc4061ed78148eda3e85e9535c35440b
https://hal.sorbonne-universite.fr/hal-01984689/document
https://hal.sorbonne-universite.fr/hal-01984689/document
Autor:
Hamza Bhugaloo, Jean-Yves Hogrel, Guillaume Bassez, Philippe Le Corvoisier, Marc Peschanski, Raphaëlle Arrouasse, Sandrine Baghdoyan, Marie-Laurence Gourlay-Chu, Etienne Audureau
Publikováno v:
Brain-A Journal of Neurology
Brain-A Journal of Neurology, 2018, 141 (10), pp.2855-2865. ⟨10.1093/brain/awy231⟩
Brain-A Journal of Neurology, 2018, 141 (10), pp.2855-2865. ⟨10.1093/brain/awy231⟩
International audience; Metformin, the well-known anti-diabetic drug, has been shown recently to improve the grip test performance of the DMSXL mouse model of myotonic dystrophy type 1. The drug may have positively affected muscle function via severa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9b6507479dbeaac55b9662128aaf30d
https://hal.archives-ouvertes.fr/hal-03875133
https://hal.archives-ouvertes.fr/hal-03875133
Autor:
Tingting Qing, Jacqueline Gide, Jérôme Alexandre Denis, Laetitia Barrault, Laetitia Aubry, Michel Cailleret, Léa Lesueur, Sandrine Baghdoyan, Cécile Martinat, Jörg Tost, Marc Peschanski
Publikováno v:
Cells
Volume 8
Issue 12
Volume 8
Issue 12
Substantial variations in differentiation properties have been reported among human pluripotent cell lines (hPSC), which could affect their utility and clinical safety. We characterized the variable osteogenic capacity observed between different huma
Autor:
Anne Boland, Jean-François Deleuze, Sandrine Baghdoyan, Cécile Martinat, Sylvia Franc, Emilie Chautard, Marc Peschanski, Christophe Battail, Xavier Nissan, François Artiguenave, Laetitia Barrault, Jacqueline Gide, Pierre Rustin, Guillaume Charpentier, Clara Benoit, Didier Auboeuf, Paule Bénit, Guillaume Bassez, Delphine Laustriat, Denis Furling
Publikováno v:
Molecular Therapy-Nucleic Acids
Molecular Therapy-Nucleic Acids, Nature Publishing Group, 2015, 4 (11), pp.e262. <10.1038/mtna.2015.35>
Molecular Therapy-Nucleic Acids, 2015, 4 (11), pp.e262. ⟨10.1038/mtna.2015.35⟩
Molecular Therapy-Nucleic Acids, Elsevier, 2015, 4 (11), pp.e262. ⟨10.1038/mtna.2015.35⟩
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 4, Iss C (2015)
Molecular Therapy-Nucleic Acids, Nature Publishing Group, 2015, 4 (11), pp.e262. <10.1038/mtna.2015.35>
Molecular Therapy-Nucleic Acids, 2015, 4 (11), pp.e262. ⟨10.1038/mtna.2015.35⟩
Molecular Therapy-Nucleic Acids, Elsevier, 2015, 4 (11), pp.e262. ⟨10.1038/mtna.2015.35⟩
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 4, Iss C (2015)
International audience; Major physiological changes are governed by alternative splicing of RNA, and its misregulation may lead to specific diseases. With the use of a genome-wide approach, we show here that this splicing step can be modified by medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c729ae1c209379b63227c845bb35f033
http://hal.upmc.fr/hal-01277500
http://hal.upmc.fr/hal-01277500
Publikováno v:
médecine/sciences. 21:535-538
À l’interface du vivant et de l’inerte, se développe un ensemble de nouvelles technologies regroupées sous le terme générique de biopuces. Grâce à la miniaturisation, nous pouvons imaginer que, demain, de nombreuses études biologiques et